Fujita Naoyuki, Jaye David L, Geigerman Cissy, Akyildiz Adil, Mooney Myesha R, Boss Jeremy M, Wade Paul A
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Cell. 2004 Oct 1;119(1):75-86. doi: 10.1016/j.cell.2004.09.014.
The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.
转录抑制因子BCL-6通过阻止B淋巴细胞终末分化为浆细胞直至接收到适当信号,从而在生发中心反应过程中调节B淋巴细胞的细胞命运。在此,我们报道了一种辅因子MTA3,它是共抑制复合物Mi-2/NuRD的细胞类型特异性亚基,参与BCL-6依赖性的细胞命运决定。MTA3在生发中心的表达模式与BCL-6相同。BCL-6与Mi-2/NuRD发生物理相互作用,且这种相互作用对BCL-6的乙酰化状态敏感。通过RNA干扰使MTA3缺失会损害BCL-6依赖性的抑制作用,并改变B淋巴细胞特有的细胞特异性转录模式。值得注意的是,在浆细胞系中外源表达BCL-6会以MTA3依赖性的方式导致浆细胞特异性转录本的抑制、B细胞转录程序的重新激活、B淋巴细胞细胞表面标志物的表达以及细胞命运的重编程。